Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
4 hedge funds and large institutions have $1.06K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
49% less capital invested
Capital invested by funds: $2.08K → $1.06K (-$1.02K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $1K | +$4 | +100 | +0.2% |
|
|
AFM
2
Anson Funds Management
Dallas,
Texas
| $60 | – | – | – |
|
PHIOW Hedge Fund Activity: Q3 2019 in Review
4 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q3 2019, worth a combined $1.06K — down 49% from $2.08K a quarter earlier.
Fund positioning in PHIOW was balanced in Q3 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $4.
- 4 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $1.06K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q3 2019, down 49% quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q3 2019 and 0 closed out.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q3 2019 was Susquehanna International Group, an estimated $4 added.
Based on aggregated 13F filings for Q3 2019.